newsfilter
← Latest News
Business Wire·

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

France and Switzerland approve INT200 for use with the INTERCEPT Blood System for Platelets and Plasma Cerus Corporation (NASDAQ:CERS) announced today two in-country regulatory approvals for INT200, one by the French